ยาปฏิชีวนะในการยับยั้งรา
C. Lass-Florl et al. (2013) Epidemiological cut-off values define the upper limit of wild-type MIC distributions showing strains with no acquired resistance mechanisms, CBPs are used to indicate isolates that are likely to respond to treatment with a given antifungal agent administered at the approved dosing regimen. in vitro susceptibility testing discriminate non-WT from WT strains of most Aspergillus species complex when testing amphotericin B and
the triazoles. Either poor response to therapy or failure has been linked to non-WT or high MICs of amphotericin B and especially itraconazole and voriconazole in isolated aspergillosis
cases. Less information is available for the echinocandins. As ECOFFs are species specific, identification of the infecting isolate to the species level is helpful in selecting an antifungal
agent.